Compugen Ltd (Israel) Financial Indicators Patterns

CGEN -- Israel Stock  

ILS 1,201  11.00  0.92%

We suggest you to use Compugen Ltd fundamental analysis to see if markets are presently mispricing the company. In plain English you can use it to find out if Compugen Ltd is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found twenty-five available fundamental indicators for Compugen Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Compugen Ltd fundamentals including its Shares Outstanding, Revenue, EBITDA, as well as the relationship between Price to Sales and Gross Profit . Use Compugen Ltd to enhance returns of your portfolios. The stock experiences moderate upward volatility. Check odds of Compugen Ltd to be traded at S1321.1 in 30 days

Compugen Ltd Company Summary

Compugen Ltd competes with Kamada Ltd, RedHill Biopharma, BioTime, Clal Biotechnology, and Pluristem Therapeutics. Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company was incorporated in 1993 and is headquartered in Holon, Israel. Compugen Ltd operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 101 people.

Compugen Ltd Number of Employees vs Gross Profit

Compugen Ltd is rated below average in number of employees category among related companies. It is rated below average in gross profit category among related companies fabricating about  4,842  of Gross Profit per Number of Employees.

Compugen Ltd Systematic Risk

Function
Time Period
  Portfolio Suggestion    
  
Execute Function
 
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of thirty-eight. The Beta measures systematic risk based on how returns on Compugen Ltd correlated with the market. If Beta is less than 0 Compugen Ltd generally moves in the opposite direction as compared to the market. If Compugen Ltd Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Compugen Ltd is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Compugen Ltd is generally in the same direction as the market. If Beta > 1 Compugen Ltd moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Compugen Ltd Total Assets Over Time

Distress Rating

Compugen Ltd Financial Distress Probability

49%
Chance of Financial Distress
Compugen Ltd has less than 49 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Compugen Ltd

Compare Compugen Ltd To Peers

Compugen Ltd Opportunity Range

December 15, 2018 Opportunity Range

Check also Trending Equities. Please also try Instant Ratings module to determine any equity ratings based on digital recommendations. macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com